- Home
- NVDA vs JNJ Comparison
NVDA vs JNJ Comparison
Compare NVDA & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVDA | JNJ |
|---|---|---|
| Founded | 1993 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9T | 542.4B |
| IPO Year | 1998 | 2003 |
Fundamental Metrics
Financial Performance| Metric | NVDA | JNJ |
|---|---|---|
| Price | $211.72 | $268.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 62 | 23 |
| Target Price | ★ $328.72 | $279.41 |
| AVG Volume (30 Days) | ★ 74.8M | 6.5M |
| Earning Date | 11-18-2026 | 10-13-2026 |
| Dividend Yield | 0.45% | ★ 2.08% |
| EPS Growth | 66.67 | ★ 90.50 |
| EPS | ★ 4.85 | 4.49 |
| Revenue | ★ $215,938,000,000.00 | N/A |
| Revenue This Year | $90.64 | $7.46 |
| Revenue Next Year | $68.15 | $6.60 |
| P/E Ratio | ★ $45.66 | $58.31 |
| Revenue Growth | ★ 65.47 | N/A |
| 52 Week Low | $164.27 | $184.66 |
| 52 Week High | $243.37 | $281.07 |
Technical Indicators
Market Signals| Indicator | NVDA | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 57.73 |
| Support Level | $208.32 | $262.26 |
| Resistance Level | $214.98 | $276.92 |
| Average True Range (ATR) | 5.26 | 5.81 |
| MACD | -2.03 | 0.95 |
| Stochastic Oscillator | 3.33 | 94.04 |
Price Performance
Historical ComparisonAbout NVDA NVIDIA Corporation
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.